NCT00964457Unknown2 期
Treatment of Patient With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before Under and After Radiation and With Adding Cetuximab to K_RAS Wild-type Patients.
Copenhagen University Hospital at Herlev1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2009年8月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- response rate
研究概览
简要总结
response rate to adding cetuximab, oxaliplatin and capecitabine to radiation for advanced rectum cancer
详细描述
Dynamic MRI will be used to monitor the effect of the treatment and will be compared to pathologic results.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •advanced rectum cancer
排除标准
- •prior radiation
研究组 & 干预措施
Capecitabine, oxaliplatin
Active Comparator
干预措施: cetuximab (Drug)
capecitabine, oxaliplatin and cetuximab
Active Comparator
capecitabine, oxaliplatin ane cetuximab
干预措施: cetuximab (Drug)
结局指标
主要结局
response rate
时间窗: 3 years
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Concurrent Chemoradiation With Concomitant Boost In Locally Advanced Rectal CancerRectal NeoplasmsNCT02723253IRCCS Azienda Ospedaliero-Universitaria di Bologna18
终止
2 期
Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal CancerRectal CancerNCT00250835New Mexico Cancer Research Alliance38
终止
2 期
Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal CancerRectal CancerNCT00611858Dana-Farber Cancer Institute13
终止
1 期
Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric CancerGastric CancerNCT01611506Dr Anna Dorothea Wagner1
进行中（未招募）
2 期
Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal CancerColorectal Cancer Stage IIColorectal Cancer Stage IIINCT04304209Sun Yat-sen University195